• AI Framework for Differentiating Neurodegenerative Diseases

    May 12, 2026, 01:01 by User Not Found
    Clinical Research News | A team of computational scientists at Lund University (Sweden) have built a deep, joint-learning proteomics model for improving the diagnostic accuracy for a handful of dementia-related conditions which in primary care settings remains challenging due to a shortage of informative biomarkers. Predicting these different but correlated pathologies together with a single blood test would facilitate a differential diagnosis with speed and confidence.
    Full story
  • Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1

    May 11, 2026, 08:11 by
    Full story
  • NunaBio secures £6.5 million to scale next-generation DNA platform and advance infrastructure for synthetic biology

    May 11, 2026, 08:11 by
    Full story
  • eClinical Solutions and Hobson & Company Quantify Financial and Operational Value of a Clinical Data Intelligence Platform for Clinical Trials

    May 11, 2026, 08:11 by
    Bringing price transparency to clinical trial technology investment and return, company unveils ROI calculator for pharmaceutical companies and CROs
    Full story
  • Strengthening Patient Recruitment Through Smarter Trial Design

    May 8, 2026, 01:01 by User Not Found
    Clinical Research News | Patient recruitment remains one of the most persistent bottlenecks in clinical research. Issues such as increasing protocol complexity, competition for eligible participants, and growing expectations around diversity are placing ever-greater pressure on study timelines. However, recruitment challenges are often a symptom of earlier decisions; when protocol feasibility is misjudged, or patient realities are not fully considered, recruitment delays become inevitable.
    Full story
  • Symeres appoints Henning Steinhagen as CEO to drive next phase of strategic growth 

    May 7, 2026, 07:27 by
    Full story
  • Hongene Demonstrates Advanced Oligonucleotide CDMO Capabilities Through Support of SiranBio’s Dual-Target siRNA Program

    May 7, 2026, 07:27 by
    Full story
  • The Scope of Things: Bridging Health Equity in Clinical Research

    May 6, 2026, 01:01 by User Not Found
    Clinical Research News | Among the shifting tides around DEI, people are finding creative ways to keep the momentum going for equitable clinical trials. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated Arc Consulting, discuss a practical look at health equity in clinical trials in the latest episode of The Scope of Things.
    Full story
  • START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

    May 5, 2026, 07:38 by
    Strengthening its clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets
    Full story
  • Much Progress Needed Planning Research to Consider Sex as a Biological Variable

    May 5, 2026, 01:01 by User Not Found
    Clinical Research News | In 2016, the National Institutes of Health (NIH) introduced a policy requiring grantees to consider sex as a biological variable in their experimental design, analyses, and reporting. Now a team from Northwestern University has assessed progress, highlighting significant room for improvement.
    Full story
  • Much Progress Needed Planning Research to Consider Sex as a Biological Variable

    May 5, 2026, 01:00 by User Not Found
    Clinical Research News | In 2016, the National Institutes of Health (NIH) introduced a policy requiring grantees to consider sex as a biological variable in their experimental design, analyses, and reporting. Now a team from Northwestern University has assessed progress, highlighting significant room for improvement.
    Full story
  • Follow the Money: AKT1-Selective Inhibitors, Vision Restoration Treatments, Neurology and Neuropsychiatric Treatments

    Apr 30, 2026, 01:01 by User Not Found
    Clinical Research News | Terremoto Biosciences advances lead AKT1-selective inhibitor programs through phase 1 clinical development; Ray Therapeutics provides support of late-stage clinical development and commercial readiness for the company’s lead program in retinitis pigmentosa; Tortugas advances its two lead candidates; and more.
    Full story
  • AddParts bolsters pharmaceutical manufacturing resilience with funding to support virtual storeroom innovations

    Apr 29, 2026, 07:33 by
    Full story
  • FDA Piloting Real-Time Review of Clinical Trial Data From AstraZeneca, Amgen

    Apr 29, 2026, 01:01 by User Not Found
    Clinical Research News | The U.S. Food & Drug Administration is piloting real-time review of data from AstraZeneca and Amgen clinical trials, both using Paradigm Health's Study Conduct platform, and has issued a call for feedback on how artificial intelligence (AI)-enabled technologies can improve efficiency, speed, and quality of decision-making in early phase clinical trials. FDA has already received and validated signals for AstraZeneca’s trial and expects this to be the first step in implementing real-time clinical trials (RTCT).
    Full story
  • Discovery Life Sciences, Mindpeak Partnership, Streamlining Communications, Rare Disease Referrals

    Apr 28, 2026, 01:00 by User Not Found
    Clinical Research News | Discovery Life Sciences and Mindpeak enter a partnership; Cenevo has launched the Labguru Customer Portal; myTomorrows and Rare Disease Research team up; and more.
    Full story
  • Axithra Appoints Lars Kongsbak as CEO to Lead Next Phase of Growth and Series A Financing

    Apr 24, 2026, 09:06 by
    Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer.
    Full story
  • Lung Cancer Trial Trends Show Geographic Concentration

    Apr 23, 2026, 01:00 by User Not Found
    Clinical Research News | In research presented this week at the American Association for Cancer Research (AACR) Annual Meeting, trends surfaced showing that between 2020 and 2024, the number of unique sites in the United States where phase I clinical trials for non-small cell lung cancer (NSCLC) were conducted decreased by 44% and became increasingly concentrated at the top 20 highest‑volume clinical trial sites largely located in major cities.
    Full story
  • Pistoia Alliance Furthers Research on Using Social Media Listening in Drug Discovery, Clinical Research

    Apr 22, 2026, 01:00 by User Not Found
    Clinical Research News | In an expansion of its advocacy work into clinical fields, the Pistoia Alliance has launched new patient research to shape the ethical use of social media listening in drug development. The work is part of its ongoing Social Media Real-World Evidence (RWE) project.
    Full story
  • iProcess Global Research launches AxisOne: the R&D operating system for the world

    Apr 21, 2026, 07:44 by
    iProcess Global Research Inc. today announced the launch of AxisOne, an AI-powered platform the company calls the R&D operating system for the world.
    Full story
  • Leinco Technologies and CellCarta Collaborate to Advance Proteomics Solutions and Applications for Drug Development

    Apr 21, 2026, 07:44 by
    Leinco Technologies and CellCarta are pleased to announce a strategic collaboration aimed at advancing proteomics solutions that will benefit the development of immuno-oncology and other targeted therapeutic modalities.
    Full story
  • «
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »